Main
>
ONCOLOGY (**)
>
Bladder Cancer>mUC ***
>
Treatment
>
USA. M. PembrolizuMAb
>
(*) EU Approval Date: 2017. 09.05
(*) EU Approval Date: 2017. 09.05's products
This section has no products